381
Views
5
CrossRef citations to date
0
Altmetric
Invited Review

Technology innovation for patients with kidney disease

, , &
Pages 424-433 | Received 11 Feb 2015, Accepted 29 Apr 2015, Published online: 09 Oct 2015

References

  • Gilg, J., Rao, A., and Fogarty, D., 2013, UK Renal Registry 16th annual report: Chapter 1 UK renal replacement therapy incidence in 2012: National and centre-specific analyses. Nephron Clinical Practice, 125, 1–27
  • Shaw, C., Pitcher, D., Pruthi, R., Fogarty, D., 2013, UK Renal Registry 16th Annual Report: Chapter 2 UK RRT Prevalence in 2012: National and Centre-specific Analyses. Nephron Clin Pract, 125:29-54
  • Care, N., 2010, Kidney Disease: Key Facts and Figures. East Midlands Public Health Obstetrics, 1–35
  • Pruthi, R., Steenkamp, R., and Feest, T., 2013, UK Renal Registry 16th annual report: Chapter 8 survival and cause of death of UK adult patients on renal replacement therapy in 2012: National and centre-specific analyses. Nephron Clinical Practice, 125, 139–169
  • Drey, N., Roderick, P., Mullee, M., and Rogerson, M., 2003, A population-based study of the incidence and outcomes of diagnosed chronic kidney disease. American Journal of Kidney Disease, 42, 677–684
  • Stewart, J., Findlay, G., Smith, N., Kelly, K., Mason, M., 2009, NCEPOD Report: Adding Insult to injury. A review of the care of patients who died in hospital with a primary diagnosis of acute kidney injury (acute renal failure). Br J Hosp Med, 70, 372. Accessed at: http://www.ncepod.org.uk/2009aki.htm
  • Hou, S.H., Bushinsky, D.A., Wish, J.B., Cohen, J.J., and Harrington, J.T., 1983, Hospital-acquired renal insufficiency: A prospective study. American Journal of Medicine, 74, 243–248
  • Shusterman, N., Strom, B.L., Murray, T.G., Morrison, G., West, S.L., and Maislin, G., 1987, Risk factors and outcome of hospital-acquired acute renal failure. Clinical epidemiologic study. American Journal of Medicine, 83, 65–71
  • Liaño, F., Junco, E., Pascual, J., Madero, R., and Verde, E., 1998, The spectrum of acute renal failure in the intensive care unit compared with that seen in other settings. The Madrid Acute Renal Failure Study Group. Kidney International Supplement, 66, S16–24
  • Cosentino, F., Chaff, C., and Piedmonte, M., 1994, Risk factors influencing survival in ICU acute renal failure. Nephrology Dialysis Transplantation, 9(Suppl 4), 179–182
  • Bellomo, R., Ronco, C., Kellum, J.A., Mehta, R.L., and Palevsky, P., 2004, Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: The Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Critical Care, 8, R204–212
  • Wisniak, J., Graham, T. II, 2013, Contributions to diffusion of gases and liquids, colloids, dialysis, and osmosis. Educacion Química, 24, 506–515
  • Philibert, J., 2005, One and a half century of diffusion: Fick, Einstein, before and beyond. Diffusion Fundamentals, 2, 1–10
  • Gokal, R., Khanna, R., Krediet, R.T., Nolph, K.D., 2nd Edition. Springer Netherlands 2000, Textbook of Peritoneal Dialysis (Springer Science & Business Media). pp. 862
  • Wizemann, V., and Benedum, J., 1994, Nephrology Dialysis Transplantation 70th Anniversary of Haemodialysis – The pioneering contribution of Georg Haas (1886-1971). Nephrology Dialysis Transplantation, 9, 1829–1831
  • Van Gijn, J., Gijselhart, J.P., and Nurmohamed, S.A., 2013, [Kolff and the artificial kidney]. Nederlands Tijdschrift voor Geneeskunde, 157, A5711
  • Blagg, C.R., 1960, The 50th anniversary of long-term hemodialysis: University of Washington Hospital. Journal of Nephrology, 24(Suppl 1), S84–S88
  • Brescia, M.J., Cimino, J.E., Appell, K., Hurwich, B.J., and Scribner, B.H., 1966, Chronic hemodialysis using venipuncture and a surgically created arteriovenous fistula. Journal of the American Society of Nephrology, 10, 193–199
  • Blagg, C.R., 2005, Home haemodialysis: “home, home, sweet, sweet home!”. Nephrology (Carlton), 10, 206–214
  • Murray, J.E., Tilney, N.L., and Wilson, R.E., 1976, Renal transplantation: A twenty-five year experience. Annals of Surgery, 184, 565–573
  • Hayama, M., Yamamoto, K., Kohori, F., and Sakai, K., 2004, How polysulfone dialysis membranes containing polyvinylpyrrolidone achieve excellent biocompatibility? Journal of Membrane Science, 234, 41–49
  • Horl, W.H., 2002, Hemodialysis Membranes: Interleukins, Biocompatibility, and Middle Molecules. Journal of the American Society of Nephrology, 13, S62–71
  • Chanard, J., Lavaud, S., Randoux, C., and Rieu, P., 2003, New insights in dialysis membrane biocompatibility: Relevance of adsorption properties and heparin binding. Nephrology & Dialysis, 18, 252–257
  • Vanholder, R., Laecke Van, S., and Glorieux, G., 2008, The middle-molecule hypothesis 30 years after: Lost and rediscovered in the universe of uremic toxicity? Journal of Nephrology, 21, 146–160
  • Vanholder, R., De Smet, R., Glorieux, G., et al., 2003, Review on uremic toxins: Classification, concentration, and interindividual variability. Kidney International, 63, 1934–1943
  • Boure, T., and Vanholder, R., 2004, Which dialyser membrane to choose? Nephrology Dialysis Transplantation, 19, 293–296
  • Drüeke, T.B., 2000, Beta2-microglobulin and amyloidosis. Nephrology Dialysis Transplantation, 15(Suppl 1), 17–24
  • Wang, A.Y., Ninomiya, T., Al-Kahwa, A., Perkovic, V., Gallagher, M.P., Hawley, C., and Jardine, M.J., 2014, Effect of hemodiafiltration or hemofiltration compared with hemodialysis on mortality and cardiovascular disease in chronic kidney failure: A systematic review and meta-analysis of randomized trials. American Journal of Kidney Disease, 63, 968–978
  • Mostovaya, I.M., Blankestijn, P.J., Bots, M.L., et al., 2014, Clinical evidence on hemodiafiltration: A systematic review and a meta-analysis. Seminars in Dialysis, 27, 119–127. Available online at: http://www.ncbi.nlm.nih.gov/pubmed/24738146. [last accessed 1 Feb 2015]
  • Penne, E.L., Blankestijn, P.J., Bots, M.L., van den Dorpel, M.A., Grooteman, M.P.C., Nubé, M.J., ter Wee, P.M., 2005, Resolving controversies regarding hemodiafiltration versus hemodialysis: The Dutch Convective Transport Study. Seminars in Dialysis, 18, 47–51
  • Nistor, I., Palmer, S.C., Craig, J.C., Saglimbene, V., Vecchio, M., Covic, A., Strippoli, G.F.M., 2014, Convective versus diffusive dialysis therapies for chronic kidney failure: An updated systematic review of randomized controlled trials. American Journal of Kidney Disease, 63, 954–967
  • Maduell, F., Moreso, F., Pons, M., Ramos, R., Mora-Macià, J., Carreras, J., Soler, J., Torres, F., Campistol, J.M., Martinez-Castelao, A., 2013, High-efficiency postdilution online hemodiafiltration reduces all-cause mortality in hemodialysis patients. Journal of the American Society of Nephrology, 24, 487–497
  • Ok, E., Asci, G., Toz, H., Ok, E.S., Kircelli, F., Yilmaz, M., Hur, E., Demirci, M.S., Demirci, C., Duman, S., Basci, A., Adam, S.M., Isik, I.O., Zengin, M., Suleymanlar, G., Yilmaz, M.E., Ozkahya, M., 2013, Mortality and cardiovascular events in online haemodiafiltration (OL-HDF) compared with high-flux dialysis: Results from the Turkish OL-HDF Study. Nephrology Dialysis Transplantation, 28, 192–202
  • Ledebo, I., 1998, Principles and practice of hemofiltration and hemodiafiltration. Artificial Organs, 22, 20–25
  • Canaud, B., and Lertdumrongluk, P., 2012, Ultrapure dialysis fluid: A new standard for contemporary hemodialysis. Nephro-urology Monthly, 4, 519–523
  • Van Tellingen, A., Grooteman, M.P., Bartels, P.C., Van Limbeek, J., Van Guldener, C., Wee, P.M., Nubé, M.J., 2001, Long-term reduction of plasma homocysteine levels by super-flux dialyzers in hemodialysis patients. Kidney International, 59, 342–347
  • Santoro, A., and Guadagni, G., 2010, Dialysis membrane: From convection to adsorption. Clinical Kidney Journal, 3(Suppl 1), i36–i39
  • Bammens, B., Evenepoel, P., Keuleers, H., Verbeke, K., and Vanrenterghem, Y., 2006, Free serum concentrations of the protein-bound retention solute p-cresol predict mortality in hemodialysis patients. Kidney International, 69, 1081–1087
  • Barreto, F.C., Barreto, D.V., Liabeuf, S., Meert, N., Glorieux, G., Temmar, M., Choukroun, G., Vanholder, R., Massy, Z.A., 2009, Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients. Clinical Journal of the American Society of Nephrology, 4, 1551–1558
  • Barreto, F.C., Barreto, D.V., Liabeuf, S., Meert, N., Glorieux, G., Temmar, M., Choukroun, G., Vanholder, R., Massy, Z.A., 2010, p-Cresol and cardiovascular risk in mild-to-moderate kidney disease. Clinical Journal of the American Society of Nephrology, 5, 1182–1189
  • Meijers, B.K.I., Bammens, B., De Moor, B., Verbeke, K., Vanrenterghem, Y., and Evenepoel, P., 2008, Free p-cresol is associated with cardiovascular disease in hemodialysis patients. Kidney International, 73, 1174–1180
  • Sirich, T.L., Luo, F.J.-G., Plummer, N.S., Hostetter, T.H., and Meyer, T.W., 2012, Selectively increasing the clearance of protein-bound uremic solutes. Nephrology Dialysis Transplantation, 27, 1574–1579
  • Johnson, D., 2013, Home dialysis can be a journey to a better quality of life. Nephrology News & Issues, 27, 42–44, 46
  • Power, A., and Ashby, D., 2014, Haemodialysis: Hospital or home? Postgraduate Medical Journal, 90, 92–97
  • Schachter, M.E., and Chan, C.T., 2012, Current state of intensive hemodialysis: A comparative review of benefits and barriers. Nephrology Dialysis Transplantation, 27, 4307–4313
  • Watanabe, Y., Ohno, Y., Inoue, T., Takane, H., Okada, H., and Suzuki, H., 2014, Home hemodialysis and conventional in-center hemodialysis in Japan: A comparison of health-related quality of life. Hemodialysis International, 18(Suppl 1), S32–38
  • Rosner, M.H., 2010, Home hemodialysis: Present state of the evidence. Dialysis Transplantation, 39, 330–334
  • Abma, I., Jayanti, A., Bayer, S., Mitra, S., and Barlow, J., 2014, Perceptions and experiences of financial incentives: A qualitative study of dialysis care in England. British Medical Journal Open, 4, e004249
  • Jayanti, A., Morris, J., Stenvinkel, P., and Mitra, S., 2014, Home hemodialysis: Beliefs, attitudes, and practice patterns. Hemodialysis International, 18, 767–776
  • Jayanti, A., Wearden, A.J., Morris, J., Brenchley, P., Abma, I., Bayer, S., Barlow, J., Mitra, S., 2013, Barriers to successful implementation of care in home haemodialysis (BASIC-HHD):1. Study design, methods and rationale. BMC Nephrology, 14, 197
  • Besarab, A., 2008, Resolved: Fistulas are preferred to grafts as initial vascular access for dialysis. Pro. Journal of the American Society of Nephrology, 19, 1629–1631
  • Donati, G., Cianciolo, G., Mauro, R., Rucci, P., Scrivo, A., Marchetti, A., Giampalma, E., Golfieri, R., Panicali, L., Iorio, M., Stella, A., La Manna, G., Stefoni, S., 2014, PTFE Grafts Versus Tunneled Cuffed Catheters for Hemodialysis: Which is the second choice when arteriovenous fistula is not feasible? Artifical Organs, 39, 134–141
  • Lok, C.E., and Mokrzycki, M.H., 2011, Prevention and management of catheter-related infection in hemodialysis patients. Kidney International, 79, 587–958
  • Niyyar, V.D., and Lok, C.E., 2013, Pros and cons of catheter lock solutions. Current Opinion in Nephrology & Hypertension, 22, 669–674
  • Oguzhan, N., Pala, C., Sipahioglu, M.H., et al., 2012, Locking tunneled hemodialysis catheters with hypertonic saline (26% NaCl) and heparin to prevent catheter-related bloodstream infections and thrombosis: A randomized, prospective trial. Renal Failure, 34, 181–188
  • Solomon, L.R., Cheesbrough, J.S., Bhargava, R., et al., 2012, Observational Study of need for thrombolytic therapy and incidence of bacteremia using taurolidine-citrate-heparin, taurolidine-citrate and heparin catheter locks in patients treated with hemodialysis. Seminars in Dialysis, 25, 233–238
  • Paglialonga, F., Consolo, S., Biasuzzi, A., Assomou, J., Gattarello, E., Patricelli, M.G., Giannini, A., Chidini, G., Napolitano, L., Edefonti, A., 2014, Reduction in catheter-related infections after switching from povidone-iodine to chlorhexidine for the exit-site care of tunneled central venous catheters in children on hemodialysis. Hemodialysis International, 18(Suppl 1), S13–18
  • Van der Veer, S.N., Ravani, P., Coentrão, L., Fluck, R., Kleophas, W., Labriola, L., Hoischeno, S.H., Noordzij, M., Jager, K.J., van Biesen, W., 2014, Barriers to adopting a fistula-first policy in Europe: An international survey among national experts. Journal of Vascular Access, 16, 113–119
  • Al-Jaishi, A.A., Oliver, M.J., Thomas, S.M., Lok, C.E., Zhang, J.C., Garg, A.X., Kosa, S.D., Quinn, R.R., Moist, L.M., 2014, Patency rates of the arteriovenous fistula for hemodialysis: A systematic review and meta-analysis. American Journal of Kidney Disease, 63, 464–478
  • Fitts, M.K., Pike, D.B., Anderson, K., and Shiu, Y.-T., 2014, Hemodynamic Shear Stress and Endothelial Dysfunction in Hemodialysis Access. Open Urology & Nephrology Journal, 7(Suppl 1 M5), 33–44
  • Dageforde, L.A., Harms, K.A., Feurer, I.D., and Shaffer, D., 2014, Increased minimum vein diameter on preoperative mapping with duplex ultrasound is associated with arteriovenous fistula maturation and secondary patency. Journal of Vascular Surgery, 61, 170–176
  • Smith, G.E., Barnes, R., and Chetter, I.C., 2014, Randomized clinical trial of selective versus routine preoperative duplex ultrasound imaging before arteriovenous fistula surgery. British Journal of Surgery, 101, 469–474
  • Bashar, K., Healy, D., Browne, L.D., Kheirelseid, E.A.H., Walsh, M.T., Clarke-Moloney, M., Burke, P.E., Kavanagh, E.G., Walsh, S.R., 2014, Role of far infra-red therapy in dialysis arterio-venous fistula maturation and survival: Systematic review and meta-analysis. PLoS One, 9, e104931
  • Parisotto, M.T., Schoder, V.U., Miriunis, C., Grassmann, A.H., Scatizzi, L.P., Kaufmann, P., Stopper, A., Marcelli, D., 2014, Cannulation technique influences arteriovenous fistula and graft survival. Kidney International, 86, 790–797
  • Muir, C.A., Kotwal, S.S., Hawley, C.M., Polkinghorne, K., Gallagher, M.P., Snelling, P., Jardine, M.J., 2014, Buttonhole cannulation and clinical outcomes in a home hemodialysis cohort and systematic review. Clinical Journal of the Amercian Society of Nephrology, 9, 110–119
  • Fontseré, N., Mestres, G., Burrel, M., Barrufet, M., Montaña, X., Arias, M., Ojeda, R., Maduell, F., Campistol, J.M., 2014, Observational study of surveillance based on the combination of online dialysance and thermodilution methods in hemodialysis patients with arteriovenous fistulas. Blood Purification, 37, 67–72
  • Fontseré, N., Mestres, G., Barrufet, M., Burrel, M., Vera, M., Arias, M., Masso, E., Cases, A., Maduell, F., Campistol, J.M., 2013, Practical utility of thermodilution versus doppler ultrasound to measure hemodialysis blood access flow. Nefrologia, 33, 325–332
  • Littler, P., Cullen, N., Gould, D., Bakran, A., and Powell, S., 2009, AngioJet thrombectomy for occluded dialysis fistulae: Outcome data. Cardiovascular & Interventional Radiolology, 32, 265–270
  • Bhat, R., McBride, K., Chakraverty, S., Vikram, R., and Severn, A., 2007, Primary cutting balloon angioplasty for treatment of venous stenoses in native hemodialysis fistulas: Long-term results from three centers. Cardiovascular & Interventional Radiolology, 30, 1166–1170; discussion 1171–1172
  • Saleh, H.M., Gabr, A.K., Tawfik, M.M., and Abouellail, H., 2014, Prospective, randomized study of cutting balloon angioplasty versus conventional balloon angioplasty for the treatment of hemodialysis access stenoses. Journal of Vascular Surgery, 60, 735–740
  • Ozkan, B., Güngör, D., Yıldırım, U.M., Harman, A., Ozen, O., and Aytekin, C., 2013, Endovascular stent placement of juxtaanastomotic stenosis in native arteriovenous fistula after unsuccessful balloon angioplasty. Iranian Journal of Radiology, 10, 133–139
  • Nassar, G.M., Glickman, M.H., McLafferty, R.B., et al., 2014, A comparison between the HeRO graft and conventional arteriovenous grafts in hemodialysis patients. Seminars in Dialysis, 27, 310–318
  • Steerman, S.N., Wagner, J., Higgins, J.A., Kim, C., Mirza, A., Pavela, J., Panneton, J.M., Glickman, M.H., 2013, Outcomes comparison of HeRO and lower extremity arteriovenous grafts in patients with long-standing renal failure. Journal of Vascular Surgery, 57, 776–783; discussion 782–783
  • Allan, B.J., Prescott, A.T., Tabbara, M., Bornak, A., and Goldstein, L.J., 2012, Modified use of the Hemodialysis Reliable Outflow (HeRO) graft for salvage of threatened dialysis access. Journal of Vascular Surgery, 56, 1127–1129
  • Glickman, M.H., 2011, HeRO Vascular Access Device. Seminars in Vascular Surgery, 24, 108–112
  • Covic, A., and Onofriescu, M., 2013, Time to improve fluid management in hemodialysis: Should we abandon clinical assessment and routinely use bioimpedance? Clinical Journal of the Amercian Society of Nephrology, 8, 1474–1475
  • Onofriescu, M., Mardare, N.G., Segall, L., Voroneanu, L., Cuşai, C., Hogaş, S., Ardeleanu, S., Nistor, I., Prisadă, O.V., Sascău, R., Covic, A., 2012, Randomized trial of bioelectrical impedance analysis versus clinical criteria for guiding ultrafiltration in hemodialysis patients: Effects on blood pressure, hydration status, and arterial stiffness. International Urology & Nephrology, 44, 583–591
  • Reddan, D.N., Szczech, L.A., Hasselblad, V., et al., 2005, Intradialytic blood volume monitoring in ambulatory hemodialysis patients: A randomized trial. Journal of the American Society of Nephrology, 16, 2162–2169
  • Passlick-Deetjen, J., Lage, C., and Jörres, A., 2001, Continuous flow peritoneal dialysis: Solution formulation and biocompatibility. Seminars in Dialysis, 14, 384–387. Available onlinne at: http://www.ncbi.nlm.nih.gov/pubmed/11679109. [last accessed 19 Apr 2015
  • Nakamura, S., and Niwa, T., 2004, Advanced glycation end-products and peritoneal sclerosis. Seminars in Nephrology, 24, 502–505. Available online at: http://www.ncbi.nlm.nih.gov/pubmed/15490420. [last accessed 19 Apr 2015]
  • Alscher, D.M., and Reimold, F., 2007, New facts about encapsulating peritoneal sclerosis as a sequel of long-term peritoneal dialysis - what can we do? Minerva Urologia e Nefrologica, 59, 269–279. Available online at: http://www.ncbi.nlm.nih.gov/pubmed/17912224. [last accessed 19 Apr 2015]
  • Warrens, A.N., 2000, The evolving role of mycophenolate mofetil in renal transplantation. QJM, 93, 15–20
  • Pascual, J., 2001, Anti-interleukin-2 receptor antibodies: Basiliximab and daclizumab. Nephrology Dialysis Transplantation, 16, 1756–1760
  • Hanaway, M.J., Woodle, E.S., Mulgaonkar, S., Peddi, V.R., Kaufman, D.B., First, M.R., Croy, R., Holman, J., 2011, Alemtuzumab Induction in Renal Transplantation. New England Journal of Medicine, 364, 1909–1919
  • Mulley, W.R., and Kanellis, J., 2011, Understanding crossmatch testing in organ transplantation: A case-based guide for the general nephrologist. Nephrology (Carlton), 16, 125–133
  • Fehr, T., and Stussi, G., 2012, ABO-incompatible kidney transplantation. Current Opinion in Organ Transplantation, 17, 376–385
  • Fuchinoue, S., Ishii, Y., Sawada, T., et al., 2011, The 5-year outcome of ABO-incompatible kidney transplantation with rituximab induction. Transplantation, 91, 853–857
  • Tanabe, K., 2007, Double-filtration plasmapheresis. Transplantation, 84(Suppl 12), S30–32
  • Taube, D., 1990, Immunoadsorption in the sensitized transplant recipient. Kidney International, 38, 350–358
  • Nanidis, T.G., Antcliffe, D., Kokkinos, C., et al., 2008, Laparoscopic versus open live donor nephrectomy in renal transplantation: A meta-analysis. Annals of Surgery, 247, 58–70
  • Gupta, N., Raina, P., and Kumar, A., 2005, Laparoscopic donor nephrectomy. Journal of Minimal Access Surgery, 1, 155–164
  • Knoll, G., 2008, Trends in kidney transplantation over the past decade. Drugs, 68(Suppl 1), 3–10
  • Blumberg, J.M., Gritsch, H., and Veale, J.L., 2011, Kidney paired donation: Advancements and future directions. Current Opinion in Organ Transplantation, 16, 380–384
  • Serur, D., and Charlton, M., 2011, Kidney paired donation 2011. Progress in Transplantation, 21, 215–218
  • Murphey, C.L., and Bingaman, A.W., 2012, Histocompatibility considerations for kidney paired donor exchange programs. Current Opinion in Organ Transplantation, 17, 427–432
  • Montgomery, R.A., Katznelson, S., Bry, W.I., et al., 2008, Successful three-way kidney paired donation with cross-country live donor allograft transport. American Journal of Transplantation, 8, 2163–2168
  • Moers, C., Smits, J.M., Maathuis, M.-H.J., Treckmann, J., van Gelder, F., Napieralski, B.P., van Kasterop-Kutz, M., van der Heide, J.J.H., Squifflet, J.-P., van Heurn, E., Kirste, G.R., Rahmel, A., Leuvenink, H.G.D., Paul, A., Pirenne, J., Ploeg, R.J., 2009, Machine Perfusion or Cold Storage in Deceased-Donor Kidney Transplantation. New England Journal of Medicine, 360, 7–19
  • Mogensen, C.E., Keane, W.F., Bennett, P.H., et al., 1995, Prevention of diabetic renal disease with special reference to microalbuminuria. Lancet, 346, 1080–1084
  • Mathiesen, E.R., Ronn, B., Jensen, T., Storm, B., and Deckert, T., 1990, Relationship between blood pressure and urinary albumin excretion in development of microalbuminuria. Diabetes, 39, 245–249
  • Parving, H.-H., Oxenboll, B., Svendsen, P.A., Christiansen, J.S., and Andersen, A.R., 1982, Early detection of patients at risk of developing diabetic nephropathy. A longitudinal study of urinary albumin excretion. European Journal of Endocrinology, 100, 550–555
  • Fassett, R.G., Venuthurupalli, S.K., Gobe, G.C., Coombes, J.S., Cooper, M.A., and Hoy, W.E., 2011, Biomarkers in chronic kidney disease: A review. Kidney International, 80, 806–821
  • Wallace, K., Mallard, A.S., Stratton, J.D., Johnston, P.A., Dickinson, S., and Parry, R.G., 2014, Use of an electronic alert to identify patients with acute kidney injury. Clinical Medicine, 14, 22–26
  • Johnson, J.P., Whitman, W., Briggs, W.A., and Wilson, C.B., 1978, Plasmapheresis and immunosuppressive agents in antibasement membrane antibody-induced Goodpasture’s syndrome. American Journal of Medicine, 64, 354–359
  • Klemmer, P.J., Chalermskulrat, W., Reif, M.S., Hogan, S.L., Henke, D.C., and Falk, R.J., 2003, Plasmapheresis therapy for diffuse alveolar hemorrhage in patients with small-vessel vasculitis. American Journal of Kidney Disease, 42, 1149–1153
  • Remuzzi, G., Chiurchiu, C., Abbate, M., Brusegan, V., Bontempelli, M., and Ruggenenti, P., 2002, Rituximab for idiopathic membranous nephropathy. Lancet, 360, 923–924
  • Shah, Y., Mohiuddin, A., Sluman, C., et al., 2012, Rituximab in anti-glomerular basement membrane disease. QJM, 105, 195–197

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.